ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,070.40
0.00%
Dow Jones
40,003.59
0.34%
Brent Oil
84.035
0.53%
Bitcoin
66,710.14
0.83%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Syndax Pharmaceuticals Inc (SNDX)

  7. Syndax Pharmaceuticals Inc (SNDX) News

SNDX

Syndax Pharmaceuticals (SNDX)

Syndax Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNDX
DateTimeSourceHeadlineSymbolCompany
05/16/20244:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/16/20244:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/15/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/15/20244:05PMPR Newswire (US)Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of DirectorsNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/09/20247:00AMPR Newswire (US)Syndax Announces Participation at the Bank of America Securities 2024 Health Care ConferenceNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/08/20247:06AMPR Newswire (US)Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/08/20247:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNDXSyndax Pharmaceuticals Inc
05/08/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNDXSyndax Pharmaceuticals Inc
05/03/20244:05PMPR Newswire (US)Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNDXSyndax Pharmaceuticals Inc
05/01/20247:00AMPR Newswire (US)Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024NASDAQ:SNDXSyndax Pharmaceuticals Inc
04/10/20244:05PMPR Newswire (US)Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:SNDXSyndax Pharmaceuticals Inc
04/08/20247:00AMPR Newswire (US)Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary SessionNASDAQ:SNDXSyndax Pharmaceuticals Inc
04/05/20244:05PMPR Newswire (US)Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNDXSyndax Pharmaceuticals Inc
03/28/20247:00AMPR Newswire (US)Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid LeukemiaNASDAQ:SNDXSyndax Pharmaceuticals Inc
03/26/20244:05PMPR Newswire (US)Syndax Announces FDA Priority Review of NDA for Revumenib for the Treatment of Relapsed/Refractory KMT2Ar Acute LeukemiaNASDAQ:SNDXSyndax Pharmaceuticals Inc
03/18/20247:00AMPR Newswire (US)Syndax Announces Appointment of Steven Closter as Chief Commercial OfficerNASDAQ:SNDXSyndax Pharmaceuticals Inc
03/01/20244:05PMPR Newswire (US)Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNDXSyndax Pharmaceuticals Inc
02/27/20245:28PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/27/20245:21PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/27/20244:05PMPR Newswire (US)Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business UpdateNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/27/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/26/20247:00AMPR Newswire (US)Syndax Announces Participation at Two Upcoming Investor ConferencesNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/20/20244:05PMPR Newswire (US)Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024NASDAQ:SNDXSyndax Pharmaceuticals Inc
02/14/202412:50PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/14/20247:01AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SNDXSyndax Pharmaceuticals Inc
02/13/20249:44PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SNDXSyndax Pharmaceuticals Inc
02/09/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/09/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/09/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNDXSyndax Pharmaceuticals Inc
02/09/20244:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNDXSyndax Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNDX

Your Recent History

EU
MLPRX
Parx Materials NV
USOTC
GNTLD
Genetic Technologies (PK)
TSXV
AIV.P
Apolo IV Acquisition
BIT
UB515T
Unicredit Bank
BIT
P12AF7
BNP PARIBAS ISSUANCE
BIT
KOR
ETF
AQSE
STVG.GB
Stv
BIT
F12439
Bank Vontobel
USOTC
GPGNF
Grupo Gigante SAB De Cv (PK)
COIN
PRMXUST
PREMA
BIT
O8JQS5
Morgan Stanley BV
BIT
IF
Banca IFIS
BIT
1SAN
Sanofi
BIT
BCM
Biancamano
BIT
S27021
Societe Generale Effekten
NASDAQ
BBHXX
Bbh US Treasury Money Fund
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved